Influenza vaccination and major cardiovascular risk: a systematic review and meta-analysis of clinical trials studies
Cardiovascular events remain a substantial global health concern, necessitating innovative strategies for prevention. This study aims to assess the potential impact of influenza vaccination on major cardiovascular events. A search of the medical English literature was conducted using PubMed/MEDLINE,...
Uloženo v:
| Vydáno v: | Scientific reports Ročník 13; číslo 1; s. 20235 - 7 |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
London
Nature Publishing Group UK
19.11.2023
Nature Publishing Group Nature Portfolio |
| Témata: | |
| ISSN: | 2045-2322, 2045-2322 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Cardiovascular events remain a substantial global health concern, necessitating innovative strategies for prevention. This study aims to assess the potential impact of influenza vaccination on major cardiovascular events. A search of the medical English literature was conducted using PubMed/MEDLINE, EMBASE, and the Cochrane CENTRAL up to 1 August 2023. Meta-analysis and stratified analyses were performed to investigate specific outcomes, including myocardial infarction (MI), cardiovascular death, and stroke. Pooled relative risks (RR) along with their 95% confidence intervals (CI) were calculated to evaluate the associations. A comprehensive analysis was conducted on a total of 9059 patients, with 4529 patients receiving the influenza vaccine and 4530 patients receiving a placebo. Among patients who received the influenza vaccine, a notable reduction in the occurrence of major cardiovascular events was observed, with 517 cases compared to 621 cases in the placebo group (RR 0.70; 95% CI 0.55–0.91). The stratified analysis revealed a decreased risk of MI in vaccinated patients (RR 0.74; 95% CI 0.56–0.97) and a significant reduction in cardiovascular death events (RR 0.67; 95% CI 0.45–0.98). This study provides compelling evidence that influenza vaccination is associated with a decreased risk of major cardiovascular events, particularly myocardial infarction, and cardiovascular death. These findings highlight the potential of influenza vaccination as an adjunctive strategy in cardiovascular disease prevention. Further research and exploration of underlying mechanisms are warranted to elucidate the observed beneficial effects. |
|---|---|
| AbstractList | Cardiovascular events remain a substantial global health concern, necessitating innovative strategies for prevention. This study aims to assess the potential impact of influenza vaccination on major cardiovascular events. A search of the medical English literature was conducted using PubMed/MEDLINE, EMBASE, and the Cochrane CENTRAL up to 1 August 2023. Meta-analysis and stratified analyses were performed to investigate specific outcomes, including myocardial infarction (MI), cardiovascular death, and stroke. Pooled relative risks (RR) along with their 95% confidence intervals (CI) were calculated to evaluate the associations. A comprehensive analysis was conducted on a total of 9059 patients, with 4529 patients receiving the influenza vaccine and 4530 patients receiving a placebo. Among patients who received the influenza vaccine, a notable reduction in the occurrence of major cardiovascular events was observed, with 517 cases compared to 621 cases in the placebo group (RR 0.70; 95% CI 0.55-0.91). The stratified analysis revealed a decreased risk of MI in vaccinated patients (RR 0.74; 95% CI 0.56-0.97) and a significant reduction in cardiovascular death events (RR 0.67; 95% CI 0.45-0.98). This study provides compelling evidence that influenza vaccination is associated with a decreased risk of major cardiovascular events, particularly myocardial infarction, and cardiovascular death. These findings highlight the potential of influenza vaccination as an adjunctive strategy in cardiovascular disease prevention. Further research and exploration of underlying mechanisms are warranted to elucidate the observed beneficial effects.Cardiovascular events remain a substantial global health concern, necessitating innovative strategies for prevention. This study aims to assess the potential impact of influenza vaccination on major cardiovascular events. A search of the medical English literature was conducted using PubMed/MEDLINE, EMBASE, and the Cochrane CENTRAL up to 1 August 2023. Meta-analysis and stratified analyses were performed to investigate specific outcomes, including myocardial infarction (MI), cardiovascular death, and stroke. Pooled relative risks (RR) along with their 95% confidence intervals (CI) were calculated to evaluate the associations. A comprehensive analysis was conducted on a total of 9059 patients, with 4529 patients receiving the influenza vaccine and 4530 patients receiving a placebo. Among patients who received the influenza vaccine, a notable reduction in the occurrence of major cardiovascular events was observed, with 517 cases compared to 621 cases in the placebo group (RR 0.70; 95% CI 0.55-0.91). The stratified analysis revealed a decreased risk of MI in vaccinated patients (RR 0.74; 95% CI 0.56-0.97) and a significant reduction in cardiovascular death events (RR 0.67; 95% CI 0.45-0.98). This study provides compelling evidence that influenza vaccination is associated with a decreased risk of major cardiovascular events, particularly myocardial infarction, and cardiovascular death. These findings highlight the potential of influenza vaccination as an adjunctive strategy in cardiovascular disease prevention. Further research and exploration of underlying mechanisms are warranted to elucidate the observed beneficial effects. Cardiovascular events remain a substantial global health concern, necessitating innovative strategies for prevention. This study aims to assess the potential impact of influenza vaccination on major cardiovascular events. A search of the medical English literature was conducted using PubMed/MEDLINE, EMBASE, and the Cochrane CENTRAL up to 1 August 2023. Meta-analysis and stratified analyses were performed to investigate specific outcomes, including myocardial infarction (MI), cardiovascular death, and stroke. Pooled relative risks (RR) along with their 95% confidence intervals (CI) were calculated to evaluate the associations. A comprehensive analysis was conducted on a total of 9059 patients, with 4529 patients receiving the influenza vaccine and 4530 patients receiving a placebo. Among patients who received the influenza vaccine, a notable reduction in the occurrence of major cardiovascular events was observed, with 517 cases compared to 621 cases in the placebo group (RR 0.70; 95% CI 0.55–0.91). The stratified analysis revealed a decreased risk of MI in vaccinated patients (RR 0.74; 95% CI 0.56–0.97) and a significant reduction in cardiovascular death events (RR 0.67; 95% CI 0.45–0.98). This study provides compelling evidence that influenza vaccination is associated with a decreased risk of major cardiovascular events, particularly myocardial infarction, and cardiovascular death. These findings highlight the potential of influenza vaccination as an adjunctive strategy in cardiovascular disease prevention. Further research and exploration of underlying mechanisms are warranted to elucidate the observed beneficial effects. Abstract Cardiovascular events remain a substantial global health concern, necessitating innovative strategies for prevention. This study aims to assess the potential impact of influenza vaccination on major cardiovascular events. A search of the medical English literature was conducted using PubMed/MEDLINE, EMBASE, and the Cochrane CENTRAL up to 1 August 2023. Meta-analysis and stratified analyses were performed to investigate specific outcomes, including myocardial infarction (MI), cardiovascular death, and stroke. Pooled relative risks (RR) along with their 95% confidence intervals (CI) were calculated to evaluate the associations. A comprehensive analysis was conducted on a total of 9059 patients, with 4529 patients receiving the influenza vaccine and 4530 patients receiving a placebo. Among patients who received the influenza vaccine, a notable reduction in the occurrence of major cardiovascular events was observed, with 517 cases compared to 621 cases in the placebo group (RR 0.70; 95% CI 0.55–0.91). The stratified analysis revealed a decreased risk of MI in vaccinated patients (RR 0.74; 95% CI 0.56–0.97) and a significant reduction in cardiovascular death events (RR 0.67; 95% CI 0.45–0.98). This study provides compelling evidence that influenza vaccination is associated with a decreased risk of major cardiovascular events, particularly myocardial infarction, and cardiovascular death. These findings highlight the potential of influenza vaccination as an adjunctive strategy in cardiovascular disease prevention. Further research and exploration of underlying mechanisms are warranted to elucidate the observed beneficial effects. |
| ArticleNumber | 20235 |
| Author | Omidi, Fatemeh Shahidi Bonjar, Amir Hashem Sarmastzadeh, Tala Nasiri, Mohammad Javad Zangiabadian, Moein |
| Author_xml | – sequence: 1 givenname: Fatemeh surname: Omidi fullname: Omidi, Fatemeh organization: Department of Cardiology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences – sequence: 2 givenname: Moein surname: Zangiabadian fullname: Zangiabadian, Moein organization: School of Medicine, Shahid Beheshti University of Medical Sciences, Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences – sequence: 3 givenname: Amir Hashem surname: Shahidi Bonjar fullname: Shahidi Bonjar, Amir Hashem organization: Clinician Scientist of Dental Materials and Restorative Dentistry, School of Dentistry, Shahid Beheshti University of Medical Sciences – sequence: 4 givenname: Mohammad Javad surname: Nasiri fullname: Nasiri, Mohammad Javad email: mj.nasiri@hotmail.com organization: School of Medicine, Shahid Beheshti University of Medical Sciences – sequence: 5 givenname: Tala surname: Sarmastzadeh fullname: Sarmastzadeh, Tala email: t.sarmastzadeh@sbmu.ac.ir organization: School of Medicine, Shahid Beheshti University of Medical Sciences |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37981651$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk1v1DAQhiNUREvpH-CALHHhEvBH7Hi4oYqPlSpxgbM1sZ3KS9YudrJo-fW4m1JQD_XFH3red2Y887w5iSn6pnnJ6FtGhX5XOiZBt5SLtusV0BaeNGecdrLlgvOT_86nzUUpW1qX5NAxeNacih40U5KdNcsmjtPi428ke7Q2RJxDigSjIzvcpkwsZhfSHotdJswkh_LjPUFSDmX2uwpbkv0--F-rxM_YYsTpUEIhaSR2CjFYnMicA06FlHlxwZcXzdOxXv3F3X7efP_08dvll_bq6-fN5Yer1nZazi1w570GrjjSHpBSTpWFkY6sB6kRhkFb1svO9RKkcEo7zwYHA6ASgg4gzpvN6usSbs1NDjvMB5MwmONDytcGc61h8mZ0SFUv_ABgO6lGQKe1FEoxAZRpUb3erF43Of1cfJnNLhTrpwmjT0sxvCZKGZNaVfT1A3Sblly_5Uj1HGrXukq9uqOWYefdfXp_m1MBvgI2p1KyH-8RRs3tEJh1CEy1M8chMLcl6wciG-ZjU-eMYXpcKlZpqXHitc__0n5E9QccYsUk |
| CitedBy_id | crossref_primary_10_1093_eurheartj_ehae569 crossref_primary_10_36660_abc_20250210 crossref_primary_10_3390_vaccines12040360 crossref_primary_10_1016_j_vaccine_2024_126356 crossref_primary_10_1093_eurjpc_zwae344 crossref_primary_10_36660_abc_20240537 crossref_primary_10_1093_eurheartj_ehaf384 crossref_primary_10_1016_j_ijcard_2025_133246 crossref_primary_10_1016_j_eclinm_2025_103449 crossref_primary_10_1371_journal_pone_0302748 crossref_primary_10_1007_s40121_024_01079_x crossref_primary_10_1371_journal_pone_0314360 crossref_primary_10_53843_bms_v10i14_1018 crossref_primary_10_36660_abc_20250210i crossref_primary_10_1038_s41541_024_00969_y crossref_primary_10_1007_s00391_025_02496_4 crossref_primary_10_1016_j_mgmed_2025_100015 crossref_primary_10_1093_cvr_cvaf092 crossref_primary_10_1371_journal_pone_0333107 crossref_primary_10_1016_j_ejim_2024_10_012 crossref_primary_10_2147_COPD_S466280 crossref_primary_10_2196_55613 crossref_primary_10_1007_s11428_025_01379_x crossref_primary_10_1093_eurjpc_zwae016 crossref_primary_10_1128_cmr_00025_24 crossref_primary_10_1093_ageing_afaf169 crossref_primary_10_3390_vaccines13050472 crossref_primary_10_1038_s41598_025_13043_x crossref_primary_10_36660_abc_20240537i |
| Cites_doi | 10.1586/14760584.2015.957191 10.1016/j.arr.2020.101124 10.1016/j.vaccine.2020.05.070 10.1056/NEJMra035098 10.7326/0003-4819-151-4-200908180-00135 10.1038/s41598-020-77679-7 10.1002/14651858.CD005050.pub3 10.1093/eurheartj/ehm581 10.1093/eurjpc/zwac285 10.1093/eurheartjsupp/suac117 10.1056/NEJMoa025028 10.1001/jamanetworkopen.2022.8873 10.1128/CMR.00097-12 10.1016/S2214-109X(22)00432-6 10.1001/jama.2021.7776 10.1093/eurheartj/ehr004 10.1161/CIRCULATIONAHA.121.057042 10.1161/01.CIR.0000016182.85461.F4 10.1007/s11886-022-01748-8 10.3389/fimmu.2020.570681 10.1056/NEJMcp1512870 10.1016/j.vaccine.2017.11.078 10.1007/978-3-540-92165-3_3 10.1002/ejhf.2993 10.1136/bmj.d5928 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2023 2023. The Author(s). The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2023 – notice: 2023. The Author(s). – notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 DOA |
| DOI | 10.1038/s41598-023-47690-9 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database CrossRef MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology Public Health |
| EISSN | 2045-2322 |
| EndPage | 7 |
| ExternalDocumentID | oai_doaj_org_article_fda0673eb99c456f9ad8853661390183 37981651 10_1038_s41598_023_47690_9 |
| Genre | Meta-Analysis Systematic Review Journal Article |
| GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFFHD AFPKN CITATION PHGZM PHGZT PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7XB 8FK K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO |
| ID | FETCH-LOGICAL-c485t-92dee89262a079a00206c9f0f17958a9bb8c1754d75953d68de1bd9b9a6330b93 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 27 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001138121600007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2045-2322 |
| IngestDate | Mon Nov 10 04:30:11 EST 2025 Thu Oct 02 09:39:41 EDT 2025 Tue Oct 07 09:13:58 EDT 2025 Mon Jul 21 06:06:35 EDT 2025 Sat Nov 29 06:05:43 EST 2025 Tue Nov 18 20:58:51 EST 2025 Fri Feb 21 02:39:42 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | 2023. The Author(s). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c485t-92dee89262a079a00206c9f0f17958a9bb8c1754d75953d68de1bd9b9a6330b93 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | https://doaj.org/article/fda0673eb99c456f9ad8853661390183 |
| PMID | 37981651 |
| PQID | 2897290234 |
| PQPubID | 2041939 |
| PageCount | 7 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_fda0673eb99c456f9ad8853661390183 proquest_miscellaneous_2892011586 proquest_journals_2897290234 pubmed_primary_37981651 crossref_primary_10_1038_s41598_023_47690_9 crossref_citationtrail_10_1038_s41598_023_47690_9 springer_journals_10_1038_s41598_023_47690_9 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-11-19 |
| PublicationDateYYYYMMDD | 2023-11-19 |
| PublicationDate_xml | – month: 11 year: 2023 text: 2023-11-19 day: 19 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Scientific reports |
| PublicationTitleAbbrev | Sci Rep |
| PublicationTitleAlternate | Sci Rep |
| PublicationYear | 2023 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | Azziz-Baumgartner, Grohskopf, Patel (CR2) 2021; 325 Moher, Liberati, Tetzlaff, Altman (CR11) 2009; 151 CR12 Behrouzi (CR25) 2022; 5 Ciszewski (CR19) 2018; 36 Gopal, Marinelli, Alcorn (CR21) 2020; 11 Cheng (CR9) 2020; 62 Aidoud (CR18) 2020; 38 Clar, Oseni, Flowers, Keshtkar-Jahromi, Rees (CR7) 2015 Nabel (CR5) 2003; 349 Treanor (CR1) 2016; 375 Maniar, Al-Abdouh, Michos (CR17) 2022; 24 CR4 Phrommintikul (CR8) 2011; 32 Nichol (CR10) 2003; 348 Ciszewski (CR15) 2008; 29 Zangiabadian (CR20) 2020; 10 Loeb (CR13) 2022; 10 CR24 Gurfinkel, de la Fuente, Mendiz, Mautner (CR16) 2002; 105 Skaarup, Modin, Nielsen, Jensen, Biering-Sørensen (CR23) 2023; 25 Wong, Webby (CR3) 2013; 26 Christopoulou, Roose, Ibañez, Saelens (CR22) 2015; 14 Li, Cao, Jing, Liu, Liu (CR6) 2023; 30 Fröbert (CR14) 2021; 144 47690_CR24 S-S Wong (47690_CR3) 2013; 26 C Clar (47690_CR7) 2015 A Ciszewski (47690_CR19) 2018; 36 A Ciszewski (47690_CR15) 2008; 29 D Moher (47690_CR11) 2009; 151 A Phrommintikul (47690_CR8) 2011; 32 YM Maniar (47690_CR17) 2022; 24 KG Skaarup (47690_CR23) 2023; 25 E Azziz-Baumgartner (47690_CR2) 2021; 325 JJ Treanor (47690_CR1) 2016; 375 47690_CR12 Y Cheng (47690_CR9) 2020; 62 EG Nabel (47690_CR5) 2003; 349 R Gopal (47690_CR21) 2020; 11 KL Nichol (47690_CR10) 2003; 348 B Behrouzi (47690_CR25) 2022; 5 O Fröbert (47690_CR14) 2021; 144 EP Gurfinkel (47690_CR16) 2002; 105 A Aidoud (47690_CR18) 2020; 38 I Christopoulou (47690_CR22) 2015; 14 Y Li (47690_CR6) 2023; 30 M Zangiabadian (47690_CR20) 2020; 10 M Loeb (47690_CR13) 2022; 10 47690_CR4 |
| References_xml | – volume: 14 start-page: 55 year: 2015 end-page: 67 ident: CR22 article-title: Influenza vaccines to control influenza-associated bacterial infection: Where do we stand? publication-title: Expert Rev. Vaccines doi: 10.1586/14760584.2015.957191 – volume: 62 start-page: 101124 year: 2020 ident: CR9 article-title: Effects of influenza vaccination on the risk of cardiovascular and respiratory diseases and all-cause mortality publication-title: Ageing Res. Rev. doi: 10.1016/j.arr.2020.101124 – volume: 38 start-page: 4944 year: 2020 end-page: 4955 ident: CR18 article-title: Influenza vaccination as a novel means of preventing coronary heart disease: Effectiveness in older adults publication-title: Vaccine doi: 10.1016/j.vaccine.2020.05.070 – ident: CR4 – ident: CR12 – volume: 349 start-page: 60 year: 2003 end-page: 72 ident: CR5 article-title: Cardiovascular disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra035098 – volume: 151 start-page: 264 year: 2009 end-page: 269 ident: CR11 article-title: Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-151-4-200908180-00135 – volume: 10 start-page: 20656 year: 2020 ident: CR20 article-title: Protective effect of influenza vaccination on cardiovascular diseases: A systematic review and meta-analysis publication-title: Sci. Rep. doi: 10.1038/s41598-020-77679-7 – year: 2015 ident: CR7 article-title: Influenza vaccines for preventing cardiovascular disease publication-title: Cochrane Database Syst. Rev. doi: 10.1002/14651858.CD005050.pub3 – volume: 29 start-page: 1350 year: 2008 end-page: 1358 ident: CR15 article-title: Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehm581 – volume: 30 start-page: 276 year: 2023 end-page: 286 ident: CR6 article-title: Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990–2019: findings from 2019 global burden of disease study publication-title: Eur. J. Prev. Cardiol. doi: 10.1093/eurjpc/zwac285 – volume: 25 start-page: A5 year: 2023 end-page: A11 ident: CR23 article-title: Influenza and cardiovascular disease pathophysiology: Strings attached publication-title: Eur. Heart J. Suppl. doi: 10.1093/eurheartjsupp/suac117 – volume: 348 start-page: 1322 year: 2003 end-page: 1332 ident: CR10 article-title: Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa025028 – volume: 5 start-page: e228873 year: 2022 end-page: e228873 ident: CR25 article-title: Association of influenza vaccination with cardiovascular risk: A meta-analysis publication-title: JAMA Netw. Open doi: 10.1001/jamanetworkopen.2022.8873 – volume: 26 start-page: 476 year: 2013 end-page: 492 ident: CR3 article-title: Traditional and new influenza vaccines publication-title: Clin. Microbiol. Rev. doi: 10.1128/CMR.00097-12 – volume: 10 start-page: e1835 year: 2022 end-page: e1844 ident: CR13 article-title: Influenza vaccine to reduce adverse vascular events in patients with heart failure: A multinational randomised, double-blind, placebo-controlled trial publication-title: Lancet Glob. Health doi: 10.1016/S2214-109X(22)00432-6 – volume: 325 start-page: 2257 year: 2021 end-page: 2259 ident: CR2 article-title: Realizing the potential of maternal influenza vaccination publication-title: Jama doi: 10.1001/jama.2021.7776 – volume: 32 start-page: 1730 year: 2011 end-page: 1735 ident: CR8 article-title: Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehr004 – volume: 144 start-page: 1476 year: 2021 end-page: 1484 ident: CR14 article-title: Influenza vaccination after myocardial infarction: A randomized, double-blind, placebo-controlled, multicenter trial publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.121.057042 – volume: 105 start-page: 2143 year: 2002 end-page: 2147 ident: CR16 article-title: Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: The FLU Vaccination Acute Coronary Syndromes (FLUVACS) study publication-title: Circulation doi: 10.1161/01.CIR.0000016182.85461.F4 – volume: 24 start-page: 1327 year: 2022 end-page: 1335 ident: CR17 article-title: Influenza vaccination for cardiovascular prevention: further insights from the IAMI trial and an updated meta-analysis publication-title: Curr. Cardiol. Rep. doi: 10.1007/s11886-022-01748-8 – volume: 11 start-page: 570681 year: 2020 ident: CR21 article-title: Immune mechanisms in cardiovascular diseases associated with viral infection publication-title: Front. Immunol. doi: 10.3389/fimmu.2020.570681 – ident: CR24 – volume: 375 start-page: 1261 year: 2016 end-page: 1268 ident: CR1 article-title: Influenza vaccination publication-title: N. Engl. J. Med. doi: 10.1056/NEJMcp1512870 – volume: 36 start-page: 202 year: 2018 end-page: 206 ident: CR19 article-title: Cardioprotective effect of influenza and pneumococcal vaccination in patients with cardiovascular diseases publication-title: Vaccine doi: 10.1016/j.vaccine.2017.11.078 – volume: 10 start-page: e1835 year: 2022 ident: 47690_CR13 publication-title: Lancet Glob. Health doi: 10.1016/S2214-109X(22)00432-6 – ident: 47690_CR4 doi: 10.1007/978-3-540-92165-3_3 – volume: 38 start-page: 4944 year: 2020 ident: 47690_CR18 publication-title: Vaccine doi: 10.1016/j.vaccine.2020.05.070 – volume: 26 start-page: 476 year: 2013 ident: 47690_CR3 publication-title: Clin. Microbiol. Rev. doi: 10.1128/CMR.00097-12 – volume: 151 start-page: 264 year: 2009 ident: 47690_CR11 publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-151-4-200908180-00135 – volume: 11 start-page: 570681 year: 2020 ident: 47690_CR21 publication-title: Front. Immunol. doi: 10.3389/fimmu.2020.570681 – volume: 5 start-page: e228873 year: 2022 ident: 47690_CR25 publication-title: JAMA Netw. Open doi: 10.1001/jamanetworkopen.2022.8873 – volume: 32 start-page: 1730 year: 2011 ident: 47690_CR8 publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehr004 – volume: 25 start-page: A5 year: 2023 ident: 47690_CR23 publication-title: Eur. Heart J. Suppl. doi: 10.1093/eurheartjsupp/suac117 – volume: 24 start-page: 1327 year: 2022 ident: 47690_CR17 publication-title: Curr. Cardiol. Rep. doi: 10.1007/s11886-022-01748-8 – volume: 10 start-page: 20656 year: 2020 ident: 47690_CR20 publication-title: Sci. Rep. doi: 10.1038/s41598-020-77679-7 – volume: 14 start-page: 55 year: 2015 ident: 47690_CR22 publication-title: Expert Rev. Vaccines doi: 10.1586/14760584.2015.957191 – volume: 325 start-page: 2257 year: 2021 ident: 47690_CR2 publication-title: Jama doi: 10.1001/jama.2021.7776 – year: 2015 ident: 47690_CR7 publication-title: Cochrane Database Syst. Rev. doi: 10.1002/14651858.CD005050.pub3 – ident: 47690_CR24 doi: 10.1002/ejhf.2993 – volume: 144 start-page: 1476 year: 2021 ident: 47690_CR14 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.121.057042 – ident: 47690_CR12 doi: 10.1136/bmj.d5928 – volume: 30 start-page: 276 year: 2023 ident: 47690_CR6 publication-title: Eur. J. Prev. Cardiol. doi: 10.1093/eurjpc/zwac285 – volume: 348 start-page: 1322 year: 2003 ident: 47690_CR10 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa025028 – volume: 36 start-page: 202 year: 2018 ident: 47690_CR19 publication-title: Vaccine doi: 10.1016/j.vaccine.2017.11.078 – volume: 62 start-page: 101124 year: 2020 ident: 47690_CR9 publication-title: Ageing Res. Rev. doi: 10.1016/j.arr.2020.101124 – volume: 375 start-page: 1261 year: 2016 ident: 47690_CR1 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMcp1512870 – volume: 105 start-page: 2143 year: 2002 ident: 47690_CR16 publication-title: Circulation doi: 10.1161/01.CIR.0000016182.85461.F4 – volume: 29 start-page: 1350 year: 2008 ident: 47690_CR15 publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehm581 – volume: 349 start-page: 60 year: 2003 ident: 47690_CR5 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra035098 |
| SSID | ssj0000529419 |
| Score | 2.5424743 |
| SecondaryResourceType | review_article |
| Snippet | Cardiovascular events remain a substantial global health concern, necessitating innovative strategies for prevention. This study aims to assess the potential... Abstract Cardiovascular events remain a substantial global health concern, necessitating innovative strategies for prevention. This study aims to assess the... |
| SourceID | doaj proquest pubmed crossref springer |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 20235 |
| SubjectTerms | 692/308 692/4019 692/699 692/700 Cardiovascular diseases Cardiovascular Diseases - prevention & control Cerebral infarction Clinical trials Death Global health Health risks Heart attacks Heart Disease Risk Factors Humanities and Social Sciences Humans Immunization Influenza Influenza Vaccines Influenza, Human - prevention & control Meta-analysis Mortality multidisciplinary Myocardial infarction Myocardial Infarction - epidemiology Myocardial Infarction - prevention & control Patients Placebos Prevention Public health Risk assessment Risk Factors Science Science (multidisciplinary) Vaccination Vaccines |
| SummonAdditionalLinks | – databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ba9VAEB60KgjipVqNVlnBN12anE2yu76IikVBSh9U-rbMXiIVm9STcwr6691bcihqX3xNdsMkM7PzZa4Az1rZ1NzjWto5wWhdcU7RdZoKZjg6L2AYk8e_fOQHB-LoSB5mh9uY0yqnMzEe1HYwwUe-538MPA70FqZ-dfqDhqlRIbqaR2hchiuhSwKLqXuHs48lRLHqSuZamZKJvdHbq1BTtvB0cf9jSOU5exTb9v8Na_4RJ43mZ__W_xJ-G25m4EleJ0m5A5dcvw3X0ijKn9twI_nvSCpLugvrD2l6yS8kZ2jMcXIaEuwtOcFvw5KYc4msJKSovyRINp2hSaqKSVvcCinm_idk6MhUkEni1JCRjCmd8R583n_36e17mkc0UFOLZkXlwjonQs9BLLnEAD5bI7uy83reCJRaC-MBSm15IxtmW2Fdpa3UElvGSi3ZDmz1Q-8eAJG6qrledLXziBQbo3nrUFvWlVgvSqkLqCZGKZP7l4cxGt9VjKMzoRJzlf_UKjJXyQKez3tOU_eOC1e_CfyfV4bO2_HCsPyqsiKrzmKY7eO0lMaDz06iFR7yeJgTvEeCFbA7iYHKx8GoNjJQwNP5tlfkEJ3B3g3ruCaAsUa0BdxPUjdTwrgUVdtUBbyYxHDz8H-_0MOLaXkE1xdBE0JSo9yFrdVy7R7DVXO2Oh6XT6Iq_QZ0wCO_ priority: 102 providerName: ProQuest |
| Title | Influenza vaccination and major cardiovascular risk: a systematic review and meta-analysis of clinical trials studies |
| URI | https://link.springer.com/article/10.1038/s41598-023-47690-9 https://www.ncbi.nlm.nih.gov/pubmed/37981651 https://www.proquest.com/docview/2897290234 https://www.proquest.com/docview/2892011586 https://doaj.org/article/fda0673eb99c456f9ad8853661390183 |
| Volume | 13 |
| WOSCitedRecordID | wos001138121600007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M~E dateStart: 20110101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M7P dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: 7X7 dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: BENPR dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: PIMPY dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M2P dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9UwDLdgA4kL4pvCeAoSN6jW78TcGNrEJPZUIUCPU-SkqTQEfeh9TIK_Hifpe9vE14WLD23aJrEt2439M8CzButKsl-b9k6VaZVLmZLrTapKK8mxgFFIHv_4Vk6najbD9kKrL58TFuGB48bt9x35XirOIFo29j1Sp9jEsFnx0boKOJ_s9VwIpiKqd4FVjmOVTFaq_SVbKl9NVvCMJIeEKV6yRAGw_3de5i8npMHwHN2Cm6PHKF7Fmd6GK264A9djD8nvd2F9HNuM_CBxRtaexr97goZOfKXP84WwlzJOhc8lfylInEM4i1i-Eh9xK0ppBCoR815sKidFaO-xFMuYd3gPPhwdvn_9Jh17KaS2UvUqxaJzTnlwQMokkvcSG4t91rNC1orQGGXZk6g6WWNddo3qXG46NEhNWWYGy_uwM8wH9xAEmrySpugrx64j1dbIxpHpyj6jqsjQJJBv9lXbEWjc97v4osOBd6l05IVmXujAC40JPN8-8y3CbPx19IFn13akh8gOF1hw9Cg4-l-Ck8Dehtl61Nul5vCTow3-VJXA0-1t1jh_jEKDm6_DGO811apJ4EEUku1MSokqb-o8gRcbqTl_-Z8X9Oh_LOgx3Ci8ePscRdyDndVi7Z7ANXu2Ol0uJnBVzmSgagK7B4fT9t0k6AzTk6L1VDLdbY9P2k8_AWJgFsc |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB5VBUQlxKO8AgWMBCeImrdtJIR4VV11WfVQUG_Gr1RFkJTNblH5UfxGxnayqwrorQeuWWeVOJ9nPo9n5gN4UvGyoMhr49qyPC5SSmNpaxWzXFNpEWDSJ49_GtPJhO3v890V-DXUwri0ysEmekNtWu1i5Ju4MUAeiB6meHX0PXaqUe50dZDQCLDYsSc_cMvWvRy9w-_7NMu23u-93Y57VYFYF6ycxTwz1jLXJk8mlEvHlyrN66RGaJZMcqWYRp9aGFryMjcVMzZVhisuK9z7K9d8CU3-BaQRGfOpgruLmI47NStS3tfmJDnb7NA_uhq2DOeB4kY05qf8n5cJ-Bu3_eNc1ru7rWv_20Rdh6s9sSavw0q4ASu2WYdLQWrzZB2uhPgkCWVXN2E-CuosPyU5llofhqAokY0h3-SXdkr0qURd4lLwXxBJlp2vSaj6CbfYmYxl39-FtDUZCk6JV0XpSBfSNW_Bx3OZg9uw2rSNvQuEq7SgKqsLi4xbllrRykpl8jqRRZZwFUE6AEPovj-7kwn5KnyeQM5EAJPATys8mASP4NninqPQneTM0W8c3hYjXWdxf6GdHojeUInaSKddZBXnGsl1zaVhSOmQxrnoGMsj2BhgJ3pz14kl5iJ4vPgZDZU7fZKNbed-jCObJasiuBNQvniSnHKWVmUawfMB9ss___cL3Tv7WR7B5e29D2MxHk127sNa5lahS-DkG7A6m87tA7ioj2eH3fShX8YEPp_3cvgNJQ1_Bg |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFH6qyiIkxFK2QAEjwQmsSeIktpEQAsqIUavRHAD1ZrwFFcGkTGaKyk_j1-ElyagCeuuBa-JEif299z4_vwXgccXLgjpei2vLCC4ySrG0tcKMaCqtA5gMweMf9-h0yvb3-WwDfvW5MD6ssteJQVGbRnsf-chtDBwPdBamGNVdWMRsZ_zy8Dv2HaT8SWvfTiNCZNce_3Dbt_bFZMet9ZM8H799_-Yd7joMYF2wcol5bqxlvmSeTCmXnjtVmtdp7WBaMsmVYtrZ18LQkpfEVMzYTBmuuKwISZUvxOTU_znqi5aHsMHZ4N_xJ2hFxrs8nZSwUetspc9ny92cULcpxfyELQwtA_7Gc_84ow2mb3z1f560a3ClI9zoVZSQ67Bh51twIbbgPN6Cy9FviWI61g1YTWLXlp8SHUmtD6KzFMm5Qd_kl2aB9IkAXuRD858jidYVsVHMBoqP2KXEsqv7gpoa9YmoKHRLaVEbwzhvwoczmYNbsDlv5vYOIK6ygqq8Lqxj4rLUilZWKkPqVBZ5ylUCWQ8Sobu67b59yFcR4gcIExFYwi2zCMASPIGnwzOHsWrJqaNfe-wNI33F8XChWXwWnQITtZG-p5FVnGtHumsuDXNUz9E77zVjJIHtHoKiU4OtWOMvgUfDbafA_KmUnNtmFcZ4ElqyKoHbEfHDlxDKWVaVWQLPehFYv_zfP3T39G95CBedFIi9yXT3HlzKvUD6uE6-DZvLxcreh_P6aHnQLh4EiUbw6ayl4TckYofD |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influenza+vaccination+and+major+cardiovascular+risk%3A+a+systematic+review+and+meta-analysis+of+clinical+trials+studies&rft.jtitle=Scientific+reports&rft.au=Omidi%2C+Fatemeh&rft.au=Zangiabadian%2C+Moein&rft.au=Shahidi+Bonjar%2C+Amir+Hashem&rft.au=Nasiri%2C+Mohammad+Javad&rft.date=2023-11-19&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=13&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-023-47690-9&rft.externalDocID=10_1038_s41598_023_47690_9 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |